CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $84,267,000 | -26.5% | 900 | -50.0% | 0.02% | -22.7% |
| Q1 2017 | $114,606,000 | -96.1% | 1,800 | -94.4% | 0.02% | -94.3% |
| Q3 2015 | $2,951,916,000 | -21.5% | 32,100 | -25.0% | 0.39% | -7.4% |
| Q2 2015 | $3,761,264,000 | +18.4% | 42,800 | 0.0% | 0.42% | +18.4% |
| Q1 2015 | $3,177,044,000 | +2366.6% | 42,800 | +1760.9% | 0.35% | +1976.5% |
| Q4 2014 | $128,800,000 | +23.5% | 2,300 | 0.0% | 0.02% | +13.3% |
| Q3 2014 | $104,328,000 | -47.5% | 2,300 | -52.1% | 0.02% | -44.4% |
| Q2 2014 | $198,768,000 | -46.4% | 4,800 | -10.3% | 0.03% | -47.1% |
| Q1 2014 | $370,595,000 | +14.9% | 5,350 | 0.0% | 0.05% | +4.1% |
| Q4 2013 | $322,445,000 | -0.8% | 5,350 | 0.0% | 0.05% | -7.5% |
| Q3 2013 | $325,173,000 | – | 5,350 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
| Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
| Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
| Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
| NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
| Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
| HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
| Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
| Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
| Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |